ImmunoPrecise Antibodies Ltd.
(NASDAQ: IPA)

ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. It owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.

2.160

-0.150 (-6.49%)
Range 2.000 - 2.410   (20.50%)
Open 2.375
Previous Close 2.310
Bid Price 2.900
Bid Volume 11
Ask Price 2.960
Ask Volume 9
Volume 2,004,715
Value -
Remark
Delayed prices. Updated at 26 Jul 2025 04:00.
Data powered by
View All Events

Share your investing ideas
Please login to view stock data and analysis